| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-895
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2003-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006518331-A |
| titleOfInvention |
vaccine |
| abstract |
The present invention relates to methods and compositions useful for the treatment and prevention of hepatitis C virus (HCV) infection and related symptoms and diseases. In particular, the invention relates to a DNA vaccine encoding an HCV core protein and a polynucleotide sequence encoding at least one other HCV protein, the vaccine causing expression of the protein in the same cell, And the sequence of the polynucleotide sequence encoding the core protein is mutated or reduced so that the negative effect of the expression of the core protein on the expression of the at least one other HCV protein is reduced. Is located relative to a polynucleotide sequence encoding the at least one other HCV protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363293-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019131566-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016513115-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006524181-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646557-B2 |
| priorityDate |
2002-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |